PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-22.52%
Both yoy net incomes decline, with CRK at -28.30%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
4.52%
D&A growth well above CRK's 8.29%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
-32.86%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
No Data
No Data available this quarter, please select a different quarter.
1999.85%
Well above CRK's 191.29% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
1999.85%
Growth well above CRK's 113.10%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
-206.74%
Both negative yoy, with CRK at -57.86%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
-32.85%
Both yoy CFO lines are negative, with CRK at -15.78%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
15.48%
Some CapEx rise while CRK is negative at -81.95%. John Neff would see competitor possibly building capacity while we hold back expansions.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
206.97%
Growth well above CRK's 94.14%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
194.71%
We have mild expansions while CRK is negative at -69.91%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
46.76%
Debt repayment growth of 46.76% while CRK is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
114.50%
We slightly raise equity while CRK is negative at -97.17%. John Neff sees competitor possibly preserving share count or buying back shares.
-44431.11%
We cut yoy buybacks while CRK is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.